| Revenue growth | 65% YoY consolidated growth; standalone up 6-7%. |
|---|---|
| Margins | EBITDA margin at 23%; expects upward bias from pharma ramp-up. |
| Order book | ₹14,000cr order book providing long-term revenue visibility. |
| Demand visibility | Strong visibility from ₹14,000cr order book over 6 years. |
| Management confidence | Balanced; focused on platform-level synergies and integration. |
Growth
Revenue grew 65% YoY; standalone revenue up 6-7% reflecting a recovery and segment diversification into pharma.
Outlook
Guided 20-25% CAGR growth over 3-5 years with peak revenue potential of ₹3,500cr from current assets.
Risks
Integration risk of multiple acquisitions and high gross debt of ₹1,500cr despite improved working capital.
Earnings Call filed with BSE, NSE: ANURAS. Summary written with AI assistance from the document.
Anupam Rasayan India Ltd: key numbers
- Share price
- ₹1,192.40
- Market cap
- ₹13,575 Cr
- Revenue (annual)
- ₹2,365 Cr
- Net profit (annual)
- ₹170.1 Cr
- P/E (TTM)
- 77.7×Sector 37.5×
- Promoter holding
- 59.07%+0.00% QoQ
- FII holding
- 7.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anupam Rasayan India Ltd
All →Anupam Rasayan India Debt & Borrowing
Anupam Rasayan India Limited has allotted non-convertible debt securities. The company filed this disclosure in accordance with SEBI LODR requirements.
Anupam Rasayan India Debt & Borrowing: ₹145 Cr
Anupam Rasayan India Ltd allotted 14,500 non-convertible debentures aggregating ₹145 Crore on a private placement basis. The proceeds will be used for debt repayment and corporate purposes.
- Value
- ₹145.0 Cr
Anupam Rasayan India Debt & Borrowing: ₹160 Cr
Anupam Rasayan India Ltd. approved the private placement issuance of 16,000 non-convertible debentures (NCDs) aggregating to ₹160 Crore to Aditya Birla Capital Limited.
- Value
- ₹160.0 Cr
- From
- Aditya Birla Capital Limited
- Execution
- 13 months
Anupam Rasayan India Debt & Borrowing: ₹300 Cr
Anupam Rasayan approved a corporate guarantee of up to ₹300 Crore and a share pledge for financing availed by its subsidiary, Mates Visa Consultancy.
- Value
- ₹300.0 Cr
Anupam Rasayan India Board Meeting Date
Anupam Rasayan India Ltd has scheduled a board meeting for September 19, 2026, to discuss potential fund-raising via a debt issue.
Anupam Rasayan India Board Meeting Date
Anupam Rasayan India Ltd announced a Board Meeting on September 19, 2026, to consider raising up to ₹160 Crore via non-convertible debentures.
- Value
- ₹160.0 Cr